ades, new acquisitions and 
strategic 
alliances. In 
April 
2023, IBA 
successfully 
launched 
a 
next-generation 
reference class electrometer DOSE-X, which 
has already reached sales of more than 300 
units. In May at ESTRO, IBA launched a 
radiation oncology risk management software 
called myQA PROactive, alongside updates to 
existing patient QA software. Post period end, IBA announced the acquisition 
of US-based Radcal Corporation, a pioneer in X-
ray imaging quality assurance.